These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6753508)

  • 41. Physiological ligands of putative LSD-serotonin receptors: heterogeneity of LSD-displacing factors in human body fluids and nervous tissue.
    Mehl E; Guiard L
    Hoppe Seylers Z Physiol Chem; 1978 Apr; 359(4):539-42. PubMed ID: 649062
    [No Abstract]   [Full Text] [Related]  

  • 42. Endogenous ligands of a putative LSD-serotonin receptor in the cerebrospinal fluid: higher level of LSD-displacing factors (LDF) in unmedicated psychotic patients.
    Mehl E; Rüther E; Redemann J
    Psychopharmacology (Berl); 1977 Aug; 54(1):9-16. PubMed ID: 410064
    [No Abstract]   [Full Text] [Related]  

  • 43. Serotonin synaptic receptors in the mammalian central nervous system.
    Bennett JP; Snyder SH
    Fed Proc; 1978 Feb; 37(2):137-8. PubMed ID: 342277
    [No Abstract]   [Full Text] [Related]  

  • 44. Receptors, receptor sensitivity, and receptor regulation in the CNS.
    Sulser F; Janowsky A
    Adv Biochem Psychopharmacol; 1982; 34():141-53. PubMed ID: 6291342
    [No Abstract]   [Full Text] [Related]  

  • 45. Independent regulation of receptor-mediated cell depolarization and adenylate cyclase by 5-hydroxytryptamine (serotonin) in neuroblastoma hybrid cells [proceedings].
    MacDermot J; Higashida H
    Biochem Soc Trans; 1979 Aug; 7(4):670-1. PubMed ID: 478126
    [No Abstract]   [Full Text] [Related]  

  • 46. Niacin and acute psychedelic psychosis.
    Goldstein JA
    Biol Psychiatry; 1984 Feb; 19(2):272-3. PubMed ID: 6713041
    [No Abstract]   [Full Text] [Related]  

  • 47. 5-Hydroxytryptamine receptor subtypes.
    Peroutka SJ
    Annu Rev Neurosci; 1988; 11():45-60. PubMed ID: 3284448
    [No Abstract]   [Full Text] [Related]  

  • 48. The characterization of 5-HT receptors. Introduction.
    Bradley PB
    Neuropharmacology; 1984 Dec; 23(12B):1465-6. PubMed ID: 6527746
    [No Abstract]   [Full Text] [Related]  

  • 49. Quantum chemical studies on molecular determinants for drug action.
    Weinstein H; Osman R; Topiol S; Green JP
    Ann N Y Acad Sci; 1981; 367():434-51. PubMed ID: 6942761
    [No Abstract]   [Full Text] [Related]  

  • 50. Loss of striatal serotonin synaptic receptor binding induced by kainic acid lesions: correlations with Huntington's Disease.
    Schwarcz R; Bennett JP; Coyle JT
    J Neurochem; 1977 Apr; 28(4):867-9. PubMed ID: 142820
    [No Abstract]   [Full Text] [Related]  

  • 51. [On the pharmacological characteristics of the serotonin-reactive structures of the heart].
    Kaverina NV; Kareva GF; Pidevich IN
    Farmakol Toksikol; 1965; 28(5):536-9. PubMed ID: 5875812
    [No Abstract]   [Full Text] [Related]  

  • 52. Biochemical effects of psychopharmacological agents.
    Mansour TE
    Psychopharmacol Bull; 1975 Jul; 11(3):65-6. PubMed ID: 1153678
    [No Abstract]   [Full Text] [Related]  

  • 53. Quantum chemical approach to the relationship between molecular structure and serotonin receptor binding affinity.
    Gómez-Jeria JS; Morales-Lagos DR
    J Pharm Sci; 1984 Dec; 73(12):1725-8. PubMed ID: 6527244
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Further evidence that vascular serotonin receptors are of the 5HT2 type.
    Cohen ML; Mason N; Wiley KS; Fuller RW
    Biochem Pharmacol; 1983 Feb; 32(3):567-70. PubMed ID: 6847706
    [No Abstract]   [Full Text] [Related]  

  • 55. Neuroreceptor activation by vibration-assisted tunneling.
    Hoehn RD; Nichols D; Neven H; Kais S
    Sci Rep; 2015 Apr; 5():9990. PubMed ID: 25909758
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serotonin as the hyperglycemic substance released by growth hormone.
    Sirek A; Geerling E; Sirek OV
    Am J Physiol; 1966 Oct; 211(4):1018-20. PubMed ID: 5926566
    [No Abstract]   [Full Text] [Related]  

  • 57. Recognition of multiple serotonin receptor binding sites.
    Peroutka SJ; Snyder SH
    Adv Biochem Psychopharmacol; 1982; 34():155-72. PubMed ID: 6753508
    [No Abstract]   [Full Text] [Related]  

  • 58. Serotonin receptor binding sites affected differentially by guanine nucleotides.
    Peroutka SJ; Lebovitz RM; Snyder SH
    Mol Pharmacol; 1979 Nov; 16(3):700-8. PubMed ID: 530255
    [No Abstract]   [Full Text] [Related]  

  • 59. Adenylate cyclase from Fasciola hepatica. 1. Ligand specificity of adenylate cyclase-coupled serotonin receptors.
    Northup JK; Mansour TE
    Mol Pharmacol; 1978 Sep; 14(5):804-19. PubMed ID: 714024
    [No Abstract]   [Full Text] [Related]  

  • 60. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol.
    Peroutka SJ; Snyder SH
    Mol Pharmacol; 1979 Nov; 16(3):687-99. PubMed ID: 530254
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.